Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary

Chapter 2 Market Overview
Overview
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry

Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities

Chapter 4 Regulatory and Reimbursement Landscape
Regulatory Scenario
U.S.
European Union
Japan
China
Reimbursement Landscape

Chapter 5 Product Pipeline for Prefilled Syringes
Overview

Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Prefilled Syringes, by Material
Global Market Size and Forecast
Glass Prefilled Syringes
Plastic Prefilled Syringes
Global Market for Prefilled Syringes, by Design
Global Market Size and Forecast
Single-Chamber Prefilled Syringes
Dual-Chamber Prefilled Syringes
Customized Prefilled Syringes
Global Market for Prefilled Syringes, by Therapeutics
Global Market Size and Forecast
Small Molecules
Monoclonal Antibodies
Vaccines
Other Therapeutics
Global Market for Prefilled Syringes, by Application
Global Market Size and Forecast
Diabetes
Cancer
Infectious Diseases
Other Applications
Geographic Breakdown
Global Market for Prefilled Syringes, by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World

Chapter 7 Competitive Intelligence
Competitive Landscape

Chapter 8 Sustainability in Prefilled Syringes: An ESG Perspective
Introduction to ESG
Sustainability in the Prefilled Syringes Market
Environmental Impact
Social Responsibility
Governance

Chapter 9 Appendix: Global Prefilled Syringes Market
Methodology
Abbreviations
Sources
Company Profiles
ARTE CORP.
BAXTER
BD
F. HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AG
HASELMEIER
NIPRO
SHL MEDICAL AG
STEVANATO GROUP
YPSOMED



List of Figures


Summary Figure : Global Market for Prefilled Syringes, by Material, 2021–2029
Figure 1 : Prefilled Syringes: Market Dynamics
Figure 2 : Distribution Share of the Five Most Frequent Cancers in Women, 2022
Figure 3 : Distribution Share of the Five Most Frequent Cancers in Men, 2022
Figure 4 : Share of Population Age 65 and Older in G7 Countries, 2021
Figure 5 : Global Shares of Population 65 and Older, by Region, 2016 and 2050
Figure 6 : Global Market for Prefilled Syringes, by Material, 2021–2029
Figure 7 : Global Market for Prefilled Syringes, by Design, 2021–2029
Figure 8 : Global Market for Prefilled Syringes, by Therapeutics, 2021–2029
Figure 9 : Global Market for Prefilled Syringes, by Application, 2021–2029
Figure 10 : Global Market for Prefilled Syringes, by Region, 2021–2029
Figure 11 : Distribution Share of Cancer Diagnoses in Europe, by Gender, 2020
Figure 12 : Global Market Shares for Prefilled Syringes, by Company, 2023
Figure 13 : Pillars of ESG
Figure 14 : Advantages of ESG for Companies
Figure 15 : Global ESG-Adoption Level Across All Industries, 2021 and 2022
Figure 16 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
Figure 19 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 20 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
Figure 22 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
Figure 23 : Nipro: Revenue Share, by Business Unit, FY 2023
Figure 24 : Nipro: Revenue Share, by Country/Region, FY 2023
Figure 25 : Stevanato Group: Revenue Share, by Business Unit, FY 2023
Figure 26 : Stevanato Group: Revenue Share, by Country/Region, FY 2023
Figure 27 : Ypsomed: Revenue Share, by Business Unit, FY 2023
Figure 28 : Ypsomed: Revenue Share, by Country/Region, FY 2023

List of Tables


Summary Table : Global Market for Prefilled Syringes, by Material, Through 2029
Table 1 : Porter’s Five Forces Analysis: Prefilled Syringes Market
Table 2 : Global Diabetes Prevalence, Estimates and Projections, 2019–2045
Table 3 : Global Prevalence of Multiple Sclerosis, by Region, 2013 and 2020
Table 4 : Global Population Growth, by Age Group, Through 2050
Table 5 : Product Pipeline for Prefilled Syringes
Table 6 : Global Market for Prefilled Syringes, by Material, Through 2029
Table 7 : Global Market for Glass Prefilled Syringes, by Region, Through 2029
Table 8 : Global Market for Plastic Prefilled Syringes, by Region, Through 2029
Table 9 : Global Market for Prefilled Syringes, by Design, Through 2029
Table 10 : Global Market for Single-Chamber Prefilled Syringes, by Region, Through 2029
Table 11 : Global Market for Dual-Chamber Prefilled Syringes, by Region, Through 2029
Table 12 : Global Market for Customized Prefilled Syringes, by Region, Through 2029
Table 13 : Global Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 14 : Global Market for Small Molecules, by Region, Through 2029
Table 15 : Global Market for Monoclonal Antibodies, by Region, Through 2029
Table 16 : Global Market for Vaccines, by Region, Through 2029
Table 17 : Global Market for Other Therapeutics, by Region, Through 2029
Table 18 : Global Market for Prefilled Syringes, by Application, Through 2029
Table 19 : Global Market for Prefilled Syringes for Diabetes, by Region, Through 2029
Table 20 : Global Market for Prefilled Syringes for Cancer, by Region, Through 2029
Table 21 : Global HIV Epidemic, by Age Group, 2021
Table 22 : Global Market for Prefilled Syringes for Infectious Diseases, by Region, Through 2029
Table 23 : Global Market for Prefilled Syringes for Other Disease Treatments, by Region, Through 2029
Table 24 : Global Market for Prefilled Syringes, by Region, Through 2029
Table 25 : Diabetes Estimates in North America, by Country, 2000–2045
Table 26 : Influenza Disease Burden in the U.S., by Age Group, 2019 and 2020 Flu Season
Table 27 : North American Market for Prefilled Syringes, by Material, Through 2029
Table 28 : North American Market for Prefilled Syringes, by Design, Through 2029
Table 29 : North American Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 30 : North American Market for Prefilled Syringes, by Application, Through 2029
Table 31 : North American Market for Prefilled Syringes, by Country, Through 2029
Table 32 : Diabetes Estimates for 10 European Countries, 2000–2045
Table 33 : European Market for Prefilled Syringes, by Material, Through 2029
Table 34 : European Market for Prefilled Syringes, by Design, Through 2029
Table 35 : European Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 36 : European Market for Prefilled Syringes, by Application, Through 2029
Table 37 : European Market for Prefilled Syringes, by Country, Through 2029
Table 38 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000–2045
Table 39 : Asia-Pacific Market for Prefilled Syringes, by Material, Through 2029
Table 40 : Asia-Pacific Market for Prefilled Syringes, by Design, Through 2029
Table 41 : Asia-Pacific Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 42 : Asia-Pacific Market for Prefilled Syringes, by Application, Through 2029
Table 43 : Asia-Pacific Market for Prefilled Syringes, by Country, Through 2029
Table 44 : Diabetes Estimates in the RoW, by Country, 2000–2045
Table 45 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 46 : RoW Market for Prefilled Syringes, by Material, Through 2029
Table 47 : RoW Market for Prefilled Syringes, by Design, Through 2029
Table 48 : RoW Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 49 : RoW Market for Prefilled Syringes, by Application, Through 2029
Table 50 : RoW Market for Prefilled Syringes, by Sub-Region, Through 2029
Table 51 : Abbreviations Used in this Report
Table 52 : Report Sources
Table 53 : ARTE Corp.: Company Snapshot
Table 54 : ARTE Corp.: Product Portfolio
Table 55 : Baxter: Company Snapshot
Table 56 : Baxter: Financial Performance, FY 2022 and 2023
Table 57 : Baxter: Product Portfolio
Table 58 : BD: Company Snapshot
Table 59 : BD: Financial Performance, FY 2022 and 2023
Table 60 : BD: Product Portfolio
Table 61 : BD: News/Key Developments, 2021 and 2022
Table 62 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 63 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 64 : F. Hoffmann-La Roche Ltd: Product Portfolio
Table 65 : Gerresheimer AG: Company Snapshot
Table 66 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
Table 67 : Gerresheimer AG: Product Portfolio
Table 68 : Haselmeier: Company Snapshot
Table 69 : Haselmeier: Product Portfolio
Table 70 : Haselmeier: News/Key Developments, 2024
Table 71 : Nipro: Company Snapshot
Table 72 : Nipro: Financial Performance, FY 2022 and 2023
Table 73 : Nipro: Product Portfolio
Table 74 : SHL Medical AG: Company Snapshot
Table 75 : SHL Medical AG: Product Portfolio
Table 76 : SHL Medical AG: News/Key Developments, 2024
Table 77 : Stevanato Group: Company Snapshot
Table 78 : Stevanato Group: Financial Performance, FY 2022 and 2023
Table 79 : Stevanato Group: Product Portfolio
Table 80 : Stevanato Group: News/Key Developments, 2023
Table 81 : Ypsomed: Company Snapshot
Table 82 : Ypsomed: Financial Performance, FY 2022 and 2023
Table 83 : Ypsomed: Product Portfolio